Company intelligence / Profile preview

Cannabit

Tel Aviv, Israeltikun-olam.org.il ↗
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Cannabit is an Israeli medical cannabis company that focuses on the research, cultivation, and distribution of pharmaceutical-grade cannabis products. The company gained significant prominence after acquiring the Israeli operations of Tikun Olam, a pioneer in the global medical cannabis industry. Cannabit operates advanced cultivation facilities and a specialized manufacturing plant that adheres to EU-GMP standards. Their product portfolio includes various oils, flowers, and specialized delivery systems designed for clinical applications in treating conditions such as chronic pain, epilepsy, and gastrointestinal disorders. The company is actively involved in clinical trials to validate the efficacy of specific cannabinoid ratios for diverse medical indications.

Therapeutic areas
PsychiatryNeurologyOncologyGastroenterology
Modalities
Small molecule
Industry
Biotech
02

Partnerships

Teva Pharmaceutical Industries

Beyond the preview

Go deeper on Cannabit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannabit.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call